NCT01878331

Long-term Study to Evaluate Different Dental Implant Alloys in Straumann 3.3mm Diameter Bone Level Implants

Name: Clinical Trial NCT01878331
Creator: Institut Straumann AG
Keywords: Jaw, Edentulous, clinical trial, Switzerland

Long-term, Prospective, Cohort Study to Evaluate Safety and Efficacy of Two Different Dental Implant Alloys in Straumann 3.3mm Diameter Bone Level Implants for Removable Prosthesis in Patients With Edentulous Mandibles

Institut Straumann AG·ClinicalTrials.govCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Jaw, Edentulous
Study type: Observational

Sponsor & location

Primary sponsor: Institut Straumann AG
Location: Geneva, Switzerland

Timeline & enrollment

Phase: N/A
Start date: Jun 01, 2013
End date: Sep 01, 2018
Enrollment: 49 participants

Primary outcome

Implant Survival

Summary

Patients with an edentulous mandible restored with implants who have participated in the core study CR 04/07 will be recruited for this extension study. No further interventions will be made for this extension study other than a clinical follow-up examination and questionnaires. Patients will not receive an investigational treatment in this study. Patients will be followed at 5 to 10 years from the date of the original implant loading

ICD-10 classifications

Dislocation of jawMottled teethDisorder of gingiva and edentulous alveolar ridge, unspecifiedOther disorders of gingiva and edentulous alveolar ridgeOther specified disorders of gingiva and edentulous alveolar ridge

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT01878331
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT01878331 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut Straumann AG and is currently Completed. The study focuses on Jaw, Edentulous. Target enrollment is 49 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.